doi: 10.1016/j.cmet.2018.05.006 61
This genetic roadmap helps explain why your plateau occurred and identifies alternative peptide targetslike tirzepatide or dual-compound protocolsthat may re-engage different biological pathways your body hasn't yet adapted to
Electrode materials for desalination of water via capacitive deionization
TB-500, VIP, and KPV remain in the preclinical stage
Several studies have reported an inverse relationship between BMI and therapeutic efficacy, indicating that obesity may attenuate clinical responses to biologic disease modifying anti-rheumatic drugs (bDMARDs)
246 Adjusting for age, sex, race/ethnicity, income, education, and food security status, individuals experiencing nutrition insecurity were 40-60% more likely to have obesity as well as type 2 diabetes, heart disease, hypertension, and hypercholesterolemia